Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
11,367,835
-
Share change
-
+11,366,669
-
Total reported value
-
$38,535,000
-
Price per share
-
$3.39
-
Number of holders
-
61
-
Value change
-
+$38,532,000
-
Number of buys
-
60
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Stock (DNABW) as of Q3 2021
As of 30 Sep 2021,
Ginkgo Bioworks Holdings, Inc. - Stock (DNABW) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,367,835 shares.
The largest 10 holders included
Diameter Capital Partners LP, CVI Holdings, LLC, Indaba Capital Management, L.P., FRANKLIN RESOURCES INC, MORGAN STANLEY, Ionic Capital Management LLC, TIGER GLOBAL MANAGEMENT LLC, Clearbridge Investments, LLC, ARISTEIA CAPITAL LLC, and GUGGENHEIM CAPITAL LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.